Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Maintains Buy on Aptinyx, Lowers Price Target to $1

HC Wainwright & Co. Maintains Buy on Aptinyx, Lowers Price Target to $1

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Aptinyx (NASDAQ:APTX) with a Buy and lowers the price target from $2 to $1.

byBenzinga Newsdesk

August 26, 2022

1 minute read

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Aptinyx (NASDAQ:APTX) with a Buy and lowers the price target from $2 to $1.

KKR & Co’s Debt Overview

By Benzinga Insights

November 10, 4:02 PM

Over the past three months, shares of KKR & Co Inc. (NYSE:KKR) decreased by 2.97%. Before having a look at the importance of debt, let's look at how much debt KKR & Co has.

KKR

Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More

By Lara Goldstein

August 3, 8:52 AM

A Revolutionary Approach: Portugal Decriminalizes Synthetic Drugs Portugal’s Parliament recently decriminalized the use of synthetic drugs. The new law equates the legal treatment of these substances with that of classic drugs.

ATAI